Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.

导出 OA

翻译打印收藏纠错

作者： Yun-Gyoo,Lee ^[1] ; Hyun,Chang ^[2] ; Bhumsuk,Keam ^[3] ; Sang Hoon,Chun ^[4] ; Jihyun,Park ^[5] ; Keon Uk,Park ^[6] ; Seong Hoon,Shin ^[7] ; Ho Jung,An ^[8] ; Kyoung Eun,Lee ^[9] ; Keun-Wook,Lee ^[10] ; Hye Ryun,Kim ^[11] ; Sung-Bae,Kim ^[12] ; Myung-Ju,Ahn ^[13] ; In Gyu,Hwang ^[14]

作者单位： Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[1] Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea. ^[2] Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. ^[3] Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea. ^[4] Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. ^[5] Department of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, Korea. ^[6] Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea. ^[7] Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ^[8] Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, Korea. ^[9] Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. ^[10] Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. ^[11] Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[12] Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[13] Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. ^[14]

关键词 Biomarkers Head and neck neoplasms Immune check point Platinum refractory Sum of target lesions